Literature DB >> 16010172

Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program.

Enrique R Pouget1, Sherry Deren, Crystal M Fuller, Shannon Blaney, James M McMahon, Sung-Yeon Kang, Stephanie Tortu, Jonny F Andia, Don C Des Jarlais, David Vlahov.   

Abstract

BACKGROUND: Effective on January 1, 2001, New York State enacted the Expanded Syringe Access Demonstration Program (ESAP), which allows syringes to be sold in pharmacies without a prescription or dispensed through doctors, hospitals, and clinics to persons 18 years of age or older and permits the possession of those syringes for the purposes of injecting drugs.
OBJECTIVE: To assess changes in receptive syringe sharing since the inception of the ESAP.
METHODS: Sociodemographic characteristics and syringe use data regarding the last injection episode were combined from 3 projects (n = 1181) recruiting injection drug users in ongoing studies in Harlem and the Bronx in New York City from January 2001 through June 2003. These data were analyzed as serial cross sections by calendar quarter.
RESULTS: Receptive sharing decreased significantly over time, from 13.4% in the first quarter to 3.6% in the last quarter. Obtaining the last injection syringe from an ESAP source (mostly pharmacies) increased significantly over time, from 7.5% in the first quarter to 25.0% in the last quarter. In multiple logistic regression analysis, variables that were significantly associated with less receptive sharing were syringe exchange and ESAP syringe source as well as time since ESAP inception. Female gender and white race/ethnicity were significantly associated with greater receptive sharing.
CONCLUSIONS: The increase in the use of pharmacies and other ESAP syringe sources in this sample has been accompanied by a decline in receptive sharing.

Entities:  

Mesh:

Year:  2005        PMID: 16010172     DOI: 10.1097/01.qai.0000152395.82885.c0

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  39 in total

1.  Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010.

Authors:  Alexandra Lutnick; Erin Cooper; Chaka Dodson; Ricky Bluthenthal; Alex H Kral
Journal:  J Urban Health       Date:  2013-04       Impact factor: 3.671

2.  Evaluating a statewide pilot syringe access program for injection drug users through pharmacies in California.

Authors:  Alex H Kral; Richard S Garfein
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

3.  Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.

Authors:  Crystal M Fuller; Sandro Galea; Wendy Caceres; Shannon Blaney; Sarah Sisco; David Vlahov
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

4.  HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.

Authors:  Barbara Tempalski; Spencer Lieb; Charles M Cleland; Hannah Cooper; Joanne E Brady; Samuel R Friedman
Journal:  J Urban Health       Date:  2008-11-18       Impact factor: 3.671

5.  Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users.

Authors:  Thomas J Stopka; Alexandra Lutnick; Lynn D Wenger; Kathryn Deriemer; Estella M Geraghty; Alex H Kral
Journal:  Am J Epidemiol       Date:  2012-05-04       Impact factor: 4.897

6.  Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study.

Authors:  Hannah Cooper; Don Des Jarlais; Zev Ross; Barbara Tempalski; Brian H Bossak; Samuel R Friedman
Journal:  J Urban Health       Date:  2012-08       Impact factor: 3.671

7.  Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.

Authors:  Natalie D Crawford; Silvia Amesty; Alexis V Rivera; Katherine Harripersaud; Alezandria Turner; Crystal M Fuller
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

8.  Temporal trends in spatial access to pharmacies that sell over-the-counter syringes in New York City health districts: relationship to local racial/ethnic composition and need.

Authors:  Hannah L F Cooper; Brian H Bossak; Barbara Tempalski; Samuel R Friedman; Don C Des Jarlais
Journal:  J Urban Health       Date:  2009-11       Impact factor: 3.671

9.  Drug-related deaths and the sales of needles through pharmacies.

Authors:  Peter J Davidson; Alexis Martinez; Alexandra Lutnick; Alex H Kral; Ricky N Bluthenthal
Journal:  Drug Alcohol Depend       Date:  2014-12-02       Impact factor: 4.492

10.  Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Authors:  Robin A Pollini; Remedios Lozada; Manuel Gallardo; Perth Rosen; Alicia Vera; Armando Macias; Lawrence A Palinkas; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.